140 related articles for article (PubMed ID: 1905365)
1. [Studies on manifestations of Rh-related hemolytic disease of the newborn in the years 1974-1989 in the Erfurt district].
Töpke B; Menzel K; Uhlig R; Pfister U
Kinderarztl Prax; 1991 Apr; 59(4):111-6. PubMed ID: 1905365
[TBL] [Abstract][Full Text] [Related]
2. [Rh (D) alloimmunization and pregnancy. Analysis of the causes after prophylaxis introduction].
Furundarena JR; Ibisate A; Burguete Y; González de Langarica E; González N; Urquiza R; Mendizabal A; Hernando N; Pérez Clausell C
Sangre (Barc); 1999 Dec; 44(6):429-33. PubMed ID: 10822755
[TBL] [Abstract][Full Text] [Related]
3. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
Spasova K; Vŭlcheva B
Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
[No Abstract] [Full Text] [Related]
4. Prevention of rhesus immunization in Australia. The first seven years.
Davey MG
Med J Aust; 1975 Aug; 2(7):263-7. PubMed ID: 808697
[TBL] [Abstract][Full Text] [Related]
5. [Advantages of preventing Rh isoimmunization].
Mikulandra F; Merlak I; Perisa M; Kapitanović Z; Barbetti V; Kimer M; Glavadanović N
Jugosl Ginekol Perinatol; 1985; 25(1-2):29-34. PubMed ID: 3003466
[TBL] [Abstract][Full Text] [Related]
6. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease.
Craig JS; McClure BG; Tubman TR
BMJ; 1998 May; 316(7144):1611. PubMed ID: 9616034
[No Abstract] [Full Text] [Related]
7. [Prevention of hemolytic disease in newborn infants using anti-D immunoglobulin G].
Mikulandra F; Perisa M; Merlak I; Kimer M; Glavadanović N
Zentralbl Gynakol; 1989; 111(7):444-52. PubMed ID: 2786664
[TBL] [Abstract][Full Text] [Related]
8. [15 years of Rh-immunization prevention program].
Eklund J; Nevanlinna HR
Katilolehti; 1984; 89(8):284-7. PubMed ID: 6441856
[No Abstract] [Full Text] [Related]
9. The fetal and neonatal outcomes of Rhesus D antibody affected pregnancies in Northern Ireland.
Craig S; Morris K; Tubman T; McClure B
Ir Med J; 2000; 93(1):17-8. PubMed ID: 10740367
[TBL] [Abstract][Full Text] [Related]
10. Fifteen years' experience with post-partum Rh prophylaxis in Norway (1969-83): incidence of new cases of anti-D and other clinically important blood group antibodies in pregnant women.
Kornstad L
NIPH Ann; 1987 Jun; 10(1):3-10. PubMed ID: 3116469
[TBL] [Abstract][Full Text] [Related]
11. Haemolytic disease of the newborn--the changing scene.
Tovey LA
Br J Obstet Gynaecol; 1986 Sep; 93(9):960-6. PubMed ID: 3094573
[TBL] [Abstract][Full Text] [Related]
12. Rh isoimmunization, Manitoba, 1963-75.
Bowman JM; Chown B; Lewis M; Pollock J
Can Med Assoc J; 1977 Feb; 116(3):282-4. PubMed ID: 402178
[TBL] [Abstract][Full Text] [Related]
13. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
Katsulov A
Akush Ginekol (Sofiia); 1997; 36(2):1-2. PubMed ID: 9471891
[No Abstract] [Full Text] [Related]
14. [Rhesus prophylaxis--history and current status].
Behrens O; Lellé RJ
Zentralbl Gynakol; 1997; 119(5):204-10. PubMed ID: 9281253
[TBL] [Abstract][Full Text] [Related]
15. [Hemolytic disease of the newborn caused by Rh incompatibility from the recent neonatologic viewpoint. I. Development of morbidity in the regions of Erfurt and Suhl following general induction of preventive anti-D therapy].
Menzel K; Kobelt L; Zimmermann U; Töpke B
Kinderarztl Prax; 1979 May; 47(5):242-50. PubMed ID: 314017
[No Abstract] [Full Text] [Related]
16. [Successes and failures in rhesus-prophylaxis].
Speiser P
Wien Med Wochenschr; 1983 Dec; 133(23-24):595-604. PubMed ID: 6420993
[TBL] [Abstract][Full Text] [Related]
17. [Development of morbidity in hemolytic disease of the newborn after the introduction of immune prophylaxis at the Rostock blood exchange center from 1970 to 1980].
Roewer J; Eggers H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(3):455-61. PubMed ID: 6194080
[TBL] [Abstract][Full Text] [Related]
18. Economics of anti-rhesus prophylaxis in an African population.
Verkuyl DA
Cent Afr J Med; 1987 Feb; 33(2):32-7. PubMed ID: 3121186
[No Abstract] [Full Text] [Related]
19. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
[TBL] [Abstract][Full Text] [Related]
20. Haemolytic disease of the newborn: the new NICE guidelines.
Thompson J
J Fam Health Care; 2002; 12(5):133-6. PubMed ID: 12449064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
